FdaApplication
ANDA 219494
Identifiers
- fda_app_no: ANDA219494
Properties
| Property | Value |
|---|---|
| applicant_name | GRAVITI PHARMACEUTICALS PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2025-01-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SPIRONOLACTONE | SPIRONOLACTONE | 50MG | TABLET;ORAL |
| SPIRONOLACTONE | SPIRONOLACTONE | 100MG | TABLET;ORAL |
| SPIRONOLACTONE | SPIRONOLACTONE | 25MG | TABLET;ORAL |
3 products